The White House approved the FDA’s more stringent guidelines for approving a Covid-19 vaccine by MattRyanPerez
The Food and Drug Administration publicly released its new guidelines for emergency use authorization for a Covid-19 vaccine, following reports that the White House was stalling on approving the recommendations because they would make it unlikely an immunization would receive approval before Election Day.headquarters on July 20, 2020 in White Oak, Maryland.
A key part of the document that has bristled the White House is the recommendation for a two-month tracking period after the final dosage is given to a clinical trial participant, all but ensuring a vaccine isn't approved for emergency use prior to the November election. The document had been blocked by the Trump administration after it was sent to the office of Chief of Staff Mark Meadows two weeks ago, according to a Monday report from theDr. Peter Marks, the head of the agency's vaccine arm, said during an interview that releasing the guidelines was meant to illustrate to the public what the agency is requiring for approval, according to the Associated Press, as the public becomes increasingly worried about a rushed vaccine.
President Trump, whose comments that a vaccine will be approved"momentarily" go against timeline predictions from health experts, previously alleged the new guidance"was a political move more than anything else." The guidelines mark another instance of health departments and the White House butting heads during the pandemic, with the Centers for Disease Control and Prevention being the center to much of the chaos."Pfizer has never discussed @US_FDA’s #COVID19 vaccine guidelines with the White House and will never do so as it could undermine the agency’s independence," tweeted the company's CEO Albert Bourla.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
House panel investigates political interference by White House over coronavirus at CDC and FDAThe subcommittee is seeking documents and information from the FDA and CDC on agency actions, drafts submitted to the White House and changes made during the review process.
Weiterlesen »
'Trump defeats COVID' coin goes on sale at unofficial White House gift shopThe coin is available for pre-order online, with buyers due to be shipped the item later in the year.
Weiterlesen »
Decision on Trump's discharge will be made later today, White House chief of staff saysWhite House Chief of Staff Mark Meadows says a decision about Trump's discharge from Walter Reed will be made later today after a consultation between the President and his doctors. Follow live updates.
Weiterlesen »
Ex-Trump FDA chief criticizes White House over coronavirus precautions to protect Trump and staff'The president didn't want to get Covid, from everything I can glean, and thought he was being protected based the testing that was in place around him,' Dr. Scott Gottlieb told CNBC on Monday.
Weiterlesen »
Three days after Trump's COVID diagnosis, White House tells staff with symptoms to stay homeThe White House has advised staffers exhibiting COVID-19 symptoms to stay at home days after the president tested positive.
Weiterlesen »
Meadows 'optimistic' Trump will leave Walter Reed, return to White House Monday after coronavirus treatmentWhite House Chief of Staff Mark Meadows said the administration is “optimistic” President Trump will be able to return to the White House on Monday after spending several days at Walter Reed National Military Medical Center being treated for coronavirus, saying Trump's health improved overnight and the president is ready to get back “to a normal working schedule.”
Weiterlesen »